Cargando…
The protective effects of lafutidine for bortezomib induced peripheral neuropathy
Peripheral neuropathy (PN) caused by bortezomib is an important complication of multiple myeloma. Subcutaneous injection of bortezomib reduced PN, but 24% of cases were grade 2 PN and 6% of cases were grade 3 PN. PN higher than grade 2 was not resolved by subcutaneous injection. PN higher than grade...
Autores principales: | Tsukaguchi, Machiko, Shibano, Masaru, Matsuura, Ai, Mukai, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712744/ https://www.ncbi.nlm.nih.gov/pubmed/23874126 http://dx.doi.org/10.2147/JBM.S44127 |
Ejemplares similares
-
Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values
por: Iida, Hiroshi, et al.
Publicado: (2009) -
Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy
por: Yamamoto, Shota, et al.
Publicado: (2021) -
Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just
for Pain
por: Zhi, W. Iris, et al.
Publicado: (2018) -
Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
por: Tang, Jing, et al.
Publicado: (2023) -
Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia
por: Maity, Somnath, et al.
Publicado: (2014)